Campisi Lab

Pierre-Yves Desprez PhD

Professor in Residence

Taming cellular senescence, the source of chronic inflammation implicated in major age-related diseases.

Lab focus

Why is aging the largest risk for developing so many apparently disparate diseases, ranging from neurodegeneration to cancer? One answer to this question lies in the evolutionarily selected, stress-responsive state termed cellular senescence. Senescent cells cease proliferation, which prevents early life cancer. They also secrete numerous molecules that promote tissue repair and regeneration. However, because senescent cells gradually accumulate with age, they eventually cause tissue degeneration, chronic inflammation, and many age-related diseases, including, ironically, late life cancer.

The Campisi lab studies the regulation and characteristics of cell states, with an emphasis on cellular senescence. We use simple and complex human and mouse cell cultures, intact human and mouse tissues, and mouse models to understand the molecular pathways that drive cellular senescence and other cell states. We also use genetic and pharmacological manipulations to understand how cell states cause both the degenerative diseases of aging as well as cancer and to design strategies to modulate or ameliorate their effects.

Why it matters

Aging is a complex, multisystem process that exacts an enormous emotional and economic toll on societies. Understanding and manipulating this process is the next big challenge in biomedical research. It is now clear that many age-related changes and pathologies are caused by cellular responses to endogenous and environmental stimuli. Understanding these responses is essential to developing safe interventions that can extend the years of healthy life in human populations.

Modern medicine has enabled us to extend lifespan - often at the expense of healthspan. My lab is focused on disrupting one of the major drivers of aging. Our goal is to enable more healthy years of life.

Judy Campisi, PhD

The Campisi lab is pleased to acknowledge the generous support of the following major funders:

Dr. Judith Campisi
1948-2024

Dr. Campisi received a PhD in biochemistry from the State University of New York at Stony Brook and completed her postdoctoral training in cell cycle regulation at the Dana-Farber Cancer Institute and Harvard Medical School. As an assistant and associate professor at the Boston University Medical School, she studied the role of cellular senescence in suppressing cancer and soon became convinced that senescent cells also contributed to aging. She joined the Lawrence Berkeley National Laboratory as a senior scientist in 1991. In 2002, she started a second laboratory at the Buck Institute. At both institutions, Dr. Campisi established a broad program to understand the relationship between aging and age-related disease, with an emphasis on the interface between cancer and aging.

Dr. Campisi is a member of the National Academy of Sciences and a fellow of the American Association for the Advancement of Science.

She has received numerous awards for her research, including two MERIT awards from the National Institute on Aging and awards from the AlliedSignal Corporation, Gerontological Society of America, and American Federation for Aging Research. She is a recipient of the Longevity prize from the IPSEN Foundation, the Bennett Cohen award from the University of Michigan, and the Schober award from Halle University, and she is the first recipient of the international Olav Thon Foundation prize in Natural Sciences and Medicine. Dr. Campisi currently serves on advisory committees for the Alliance for Aging Research, Progeria Research Foundation, and NIA’s Intervention Testing Program. She is also an editorial board member for more than a dozen peer-reviewed journals. Dr. Campisi is a scientific founder of Unity Biotechnology, a California-based company focused on developing therapies for age-related pathologies. She has served on the scientific advisory boards of the Geron Corporation, Sierra BioScience, and Sangamo Biosciences.

  • Tesfahun Admasu  Visiting Scientist

    Dr. Admasu is a research fellow at SENS Research Foundation. He is currently working on characterizing primary and secondary senescent cells and identification of novel senotherapeutics. Dr. Admasu received his PhD in biochemistry from National University of Singapore, Singapore. In his PhD, he works on identification of drug synergy for lifespan extension in C. elegans.

    tesfahun.admasu@sens.org

  • Karen Davis , MD  Visiting scientist

    Dr. Davis had a career as an anesthesiologist and general medicine practitioner in the community. At present, she is interested in mechanisms of inflammation and aging. She has a particular interest in the degenerative disease sporadic inclusion body myositis as well as sarcopenia associated with aging. Karen Davis is an Independent Visiting Scientist

    KArendavis47@gmail.com

  • Hideto Deguchi  Research Scholar

    Dr. Deguchi completed medical school and received a PhD in medicine from Kyoto Prefectural University of Medicine, Japan. During his PhD studies, he studied the relationship between intracellular pH and mitochondrial homeostasis in corneal endothelial cells. He specializes in ophthalmology, particularly uveitis, and his research focus is cellular and immune senescence in the eye.

    HDeguchi@buckinstitute.org

  • Pierre-Yves Desprez, PhD  Senior Staff Scientist, Scientific Consultant

    Dr. Pierre-Yves Desprez first joined the Berkeley National Laboratory after completion of his doctoral thesis at the University of Lyon in France. Dr. Desprez has been a Principal Investigator at the California Pacific Medical Center Research Institute in San Francisco since 1996. The Desprez laboratory is focused on helix-loop-helix transcriptional regulators, their role in regulating cancer progression, as well as on the effects of non-psychotropic cannabinoid compounds to control their expression. As part as the CPMC Precision Medicine Project, Dr. Desprez leads DNA/RNA sequencing and molecular profiling efforts, and, at the Buck Institute, he is a consulting scientist for the Campisi laboratory.

  • Tyler Hilsabeck, PhD  Postdoctoral Researcher

    Dr. Tyler Hilsabeck is a Postdoctoral Researcher in Dr. Judy Campisi’s lab. He holds a bachelor's degree in physics from Texas Tech University and a master's degree in biology from the University of Texas at San Antonio. His PhD studies in both the Kapahi and Brem labs focused on using computational and biological tools to understand the relationships between metabolites, genes, and aging-related phenotypes in Drosophila melanogaster. Dr. Hilsabeck's current research involves understanding the connection between aging, DNA damage, mortality, and risk for developing Alzheimer’s Disease. His interests include understanding the mechanisms that underly aging-related phenotypes, individual variation in lifespan and healthspan, and using computational methods to facilitate these endeavors.

    THilsabeck@buckinstitute.org

  • Brendan Hughes  PhD Student, USC-Buck Biology of Aging Program

    Brendan received his B.S. in biological sciences from Cal Poly, San Luis Obispo in December 2020. After an internship at Rubedo Life Sciences in 2019, Brendan discovered his passion for the biology of aging and is excited to continue research in this field in the Campisi lab as a PhD student studying DNA damage response in the aging brain."

    BHughes@buckinstitute.org

  • Koji Kitazawa, MD, PhD  Visiting Scientist

    Dr. Kitazawa completed medical school and received a PhD in medicine from Kyoto Prefectural University of Medicine, Japan. During his PhD student, he studied the cellular reprogramming of corneal epithelial cells at Center for iPS Research and Application (CiRA), Kyoto University. He specializes in ophthalmology, and his research focus is cellular senescence in the eye, and he is currently investigating the way to keep more healthy years of the eye longer in the Campisi lab. Dr. Kitazawa is visiting from Kyoto University

    kkitazaw@koto.kpu-m.ac.jp

  • Francesco Neri  Pre-doctoral Fellow

    Francesco received his B.S. in biotechnology at the University of Bologna (Italy) in 2017 and then completed his M.S. in pharmaceutical biotechnology at the University of Bologna (Italy) in 2019. He joined the Campisi lab in 2019 where he works on cellular senescence and senescence-associated exosomes.

    FNeri@buckinstitute.org

  • Kohsaku Numa, PhD  Postdoctoral Researcher

    Dr. Numa completed medical school and received a PhD in medicine from Kyoto Prefectural University of Medicine (KPUM), Japan. He specialized in ophthalmology. As a PhD student he student the cellular metabolism of human corneal endothelial cells. In the Campisi lab he is investigating ways to extend the healthspan of the eyes.

    KNuma@buckinstitute.org

  • Amit Sharma, PhD  Visiting Scientist

    Dr. Amit Sharma was awarded a Master’s degree in biomedical sciences from Delhi University, India. He received his PhD in 2009 in biotechnology from the University of Pune for his work demonstrating microRNA regulation of cytokines involved in allergic inflammation in mice models. Dr. Sharma’s postdoctoral research at the Buck Institute involved investigating novel molecular regulatory pathways in the context of genotoxic stress and cellular senescence in invertebrate and mammalian models. His laboratory at SENS Research Foundation focuses on investigating the mechanisms responsible for increased senescence burden with aging and the decline in immune surveillance of senescent cells or propagation by paracrine mechanisms. In addition, we are devising novel immune-based therapeutic interventions like CAR-NK cells based on several novel seno-antigens identified in the lab in cell culture and mice models of senescence.

  • Selma Takajjart  Research Associate

    stakajjart@buckinstitute.org

  • Corey Webster, PhD  Postdoctoral Researcher

    Corey is originally from Martinez, California. He completed his BS in Neuroscience at UCLA in 2002. After graduating, he worked as an RA at Stanford, UCSF and Genentech, and obtained a MS from SFSU in 2008. He began his PhD in 2013 in MCB at UC Berkeley where he studied the role of a Trp channel (TrpM3) as the receptor for the steroid hormone, pregnenolone sulfate, during circuit assembly of the retina under the mentorship of Marla Feller. Corey earned his PhD in 2019 and then joined the Campisi lab to better understand the role of specific types of senescent cells in the context of neurodegeneration. When not in the lab, Corey can be spotted on the local trails.

    CWebster@buckinstitute.org

  • Zhixin (Alice) Zhang  Research Associate

    Alice received her B.S. in bioengineering from UC Berkeley in 2022 with a concentration in cell and tissue engineering. While at Berkeley, Alice studied muscle aging and rejuvenation in Dr. Irina Conboy’s laboratory, which propelled her towards the field of aging research. She joined the Campisi lab as a research associate in May 2023.

    zzhang@buckinstitute.org

Rowena Abulencia
Administrative Lab Coordinator
RAbulencia@buckinstitute.org
Phone: 415-209-2206


Judy Campisi, PhD
Professor
JCampisi@buckinstitute.org
Phone: 415-209-2066
Selected Publications
  • Wiley CD, Sharma R, Davis SS, Lopez-Dominguez JA, Mitchell KP, Wiley S, Alimirah F, Kim DE, Payne T, Rosko A, Aimontche E, Deshpande SM, Neri F, Kuehnemann C, Demaria M, Ramanathan A, Campisi J. 2021. Oxylipin biosynthesis reinforces cellular senescence and allows detection of senolysis. Cell Metab 33:1124-1136. 

  • Dimri, G., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens ,M., Rubelj, I., Pereira-Smith, O., Peacocke, M., Campisi, J. (1195 Sep 26). A novel biomarker identifies senescent human cells in culture and aging skin in vivo. Proc Natl Acad Sci USA, 92(20), 9363–67.

  • Krtolica, A., Parrinello, S., Lockett, S., Desprez, P., Campisi, J. (2001 Oct 9). Senescent fibroblasts promote epithelial cell growth and tumorigenesis: A link between cancer and aging. Proc Natl Acad Sci USA, 98(21), 12072–77.
  • Coppe, J. P., Patil, C. K., Rodier, F., Sun, Y., Munoz, D. P., Goldstein, J., Nelson, P. S., Desprez, P. Y., Campisi, J. (2008). Senescence-associated secretory phenotypes reveal cell non-autonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol, 6(12), 2853–68.
  • Rodier, F., Coppe, J. P., Patil, C. K., Hoeijmakers, W. A. M., Munoz, D. P., Raza, S. R., Freund, A., Campeau, E., Davalos, A. R., Campisi, J. (2009 Aug). Persistent DNA damage signaling triggers senescence-associated inflammatory cytokine secretion. Nature Cell Biol, 11(8), 973–79.
  • Demaria, M., Ohtani, N., Youssef, S. A., Rodier, F., Toussaint, W., Mitchell, J. R., Laberge, R. M., Vijg, J., van Steeg, H., Dolle, M. E., Hoeijmakers, J. H., de Bruin, A., Hara, E., Campisi, J. (2014 Dec 22). An essential role for senescent cells in optimal wound healing through secretion of PDGF-AA. Dev Cell, 31(6), 722–33.
  • Laberge, R. M., Sun, Y., Orjalo, A. V., Patil, P. K., Freund, A., Zhou L., Curran, S. C., Davalos, A. R., Wilson-Edell, K. A., Liu, S., Limbad, C., Demaria, M., Li P., Hubbard, G. B., Ikeno, Y., Javors, M., Desprez, P. Y., Benz, C. C., Kapahi, P., Nelson, P. S., Campisi, J. (2015 Aug). mTOR regulates the tumor-promoting senescence secretory phenotype by promoting IL-1 translation. Nature Cell Biol, 17(8), 1049–61.
  • Velarde, M. C., Demaria, M., Melov, S., Campisi, J. (2015 Aug 18). Pleiotropic age-dependent effects of mitochondrial dysfunction on epidermal stem cells. Proc Natl Acad Sci USA, 112(33), 10407–12.
  • Wiley, C. D., Velarde, M. C., Lecot, P., Liu, S., Sarnoski, E. A., Shirakawa, K., Lim, H., Davis, S., Ramanathan, A., Gerencser, A. A., Verdin, E., Campisi, J. (2015 Dec 10). Mitochondrial dysfunction induces senescence with a distinct secretory phenotype. Cell Metab, 23(2), 303–14.
  • Demaria, M., O’Leary,, M. N., Chang J., Shao, L., Liu, S., Alimirah, F., Koenig, K., Le, C., Mitin, N., Deal, A. M., Alston, S., Academia, E. C., Kilmarx, S., Valdovinos, A., Wang, B., de Bruin, A., Kennedy, B. K., Melov, S., Zhou, D., Sharpless, N. E., Muss, H., Campisi, J. (2017 Feb). Cellular senescence promotes adverse effects of chemotherapy and cancer relapse. Cancer Discov, 7(2), 165–176.

Could getting rid of old cells turn back the clock on aging?

Want to add healthy years to your life? Here’s what new longevity research says.

Campisi Lab to partner with pharma firm on senescence

Senescence field must learn lessons from gene therapy mistakes

Biomarker Discovery Reveals Role of Lipids in Age-Related Pathologies

The Science of Aging

Zombie cells hold clues to COPD progression

Can Destroying Senescent Cells Treat Age-Related Disease?

Proteomics, "Zombie" Cells and Clinical Biomarkers of Aging

People’s Body Systems Age at Different Rates

Experts propose new healthcare framework to help ageing populations stay healthier longer

Senescent Cells Promote Blood Clotting

Scientists hunt zombie cells: ‘The grand challenge’

A cell-killing strategy to slow aging passed its first test this year

MIT Technology Review profiles Judy Campisi and her research on cellular senescence

A Biotech Entrepreneur Aims To Help Us Stay Young While Growing Old

Why do we grow old?

Can Human Mortality Really Be Hacked?

Silicon Valley’s Quest to Live Forever

Judith Campisi, Ph.D. on Cellular Senescence, Mitochondrial Dysfunction, Cancer & Aging

Professor Judith Campisi, PhD presents at Buck Member event: Taming Inflammaging: Undoing the Lynchpin Common to Most Age-Related Diseases

Norway calls Buck Institute aging researcher with cash

View all

Support the Buck

We rely on donations to support the science that we believe will add years to people's lifespan and decades to their healthspan.